Cargando…
The prevalence of chronic kidney disease in South Africa - limitations of studies comparing prevalence with sub-Saharan Africa, Africa, and globally
BACKGROUND: Chronic kidney disease (CKD) is a globally significant non-communicable disorder. CKD prevalence varies between countries and within a country. We compared the prevalence rates of CKD in South Africa with sub-Saharan Africa, Africa, and globally. METHODS: We registered a systematic revie...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029276/ https://www.ncbi.nlm.nih.gov/pubmed/36944928 http://dx.doi.org/10.1186/s12882-023-03109-1 |
_version_ | 1784910106448625664 |
---|---|
author | Hariparshad, Sudesh Bhimma, Rajendra Nandlal, Louansha Jembere, Edgar Naicker, Saraladevi Assounga, Alain |
author_facet | Hariparshad, Sudesh Bhimma, Rajendra Nandlal, Louansha Jembere, Edgar Naicker, Saraladevi Assounga, Alain |
author_sort | Hariparshad, Sudesh |
collection | PubMed |
description | BACKGROUND: Chronic kidney disease (CKD) is a globally significant non-communicable disorder. CKD prevalence varies between countries and within a country. We compared the prevalence rates of CKD in South Africa with sub-Saharan Africa, Africa, and globally. METHODS: We registered a systematic review with the International Prospective Register of Systematic Reviews for prevalence studies reporting CKD stages III-V from 2013 to 2021. The analysis sought to explain any significant differences in prevalence rates. The R statistical package was used for data analysis. Comparisons included measures of effect size due to the large sample sizes analysed. We also compared sex differences in prevalence rates, common aetiologies, and type of study methodologies employed. RESULTS: Eight studies were analysed, with two from each region. The matched prevalence rates of CKD between the various regions and South Africa showed significant differences, except for one comparison between South Africa and an African study [p = 0.09 (95% CI − 0.04–0.01)]. Both sub-Saharan African studies had a higher prevalence than South Africa. One study in Africa had a higher prevalence, while the other had a lower prevalence, whilst one Global study had a higher prevalence, and the other had a lower prevalence compared to South Africa. The statistical differences analysed using the Cramer’s V test were substantially less than 0.1. Thus, differences in comparisons were largely due to differences in sample sizes rather than actual differences. CONCLUSION: Variable prevalence rates between regions included disparities in sample size, definitions of CKD, lack of chronicity testing and heterogeneous laboratory estimations of eGFR. Improved consistency and enhanced methods for diagnosing and comparing CKD prevalence are essential. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-023-03109-1. |
format | Online Article Text |
id | pubmed-10029276 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-100292762023-03-22 The prevalence of chronic kidney disease in South Africa - limitations of studies comparing prevalence with sub-Saharan Africa, Africa, and globally Hariparshad, Sudesh Bhimma, Rajendra Nandlal, Louansha Jembere, Edgar Naicker, Saraladevi Assounga, Alain BMC Nephrol Research BACKGROUND: Chronic kidney disease (CKD) is a globally significant non-communicable disorder. CKD prevalence varies between countries and within a country. We compared the prevalence rates of CKD in South Africa with sub-Saharan Africa, Africa, and globally. METHODS: We registered a systematic review with the International Prospective Register of Systematic Reviews for prevalence studies reporting CKD stages III-V from 2013 to 2021. The analysis sought to explain any significant differences in prevalence rates. The R statistical package was used for data analysis. Comparisons included measures of effect size due to the large sample sizes analysed. We also compared sex differences in prevalence rates, common aetiologies, and type of study methodologies employed. RESULTS: Eight studies were analysed, with two from each region. The matched prevalence rates of CKD between the various regions and South Africa showed significant differences, except for one comparison between South Africa and an African study [p = 0.09 (95% CI − 0.04–0.01)]. Both sub-Saharan African studies had a higher prevalence than South Africa. One study in Africa had a higher prevalence, while the other had a lower prevalence, whilst one Global study had a higher prevalence, and the other had a lower prevalence compared to South Africa. The statistical differences analysed using the Cramer’s V test were substantially less than 0.1. Thus, differences in comparisons were largely due to differences in sample sizes rather than actual differences. CONCLUSION: Variable prevalence rates between regions included disparities in sample size, definitions of CKD, lack of chronicity testing and heterogeneous laboratory estimations of eGFR. Improved consistency and enhanced methods for diagnosing and comparing CKD prevalence are essential. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-023-03109-1. BioMed Central 2023-03-21 /pmc/articles/PMC10029276/ /pubmed/36944928 http://dx.doi.org/10.1186/s12882-023-03109-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Hariparshad, Sudesh Bhimma, Rajendra Nandlal, Louansha Jembere, Edgar Naicker, Saraladevi Assounga, Alain The prevalence of chronic kidney disease in South Africa - limitations of studies comparing prevalence with sub-Saharan Africa, Africa, and globally |
title | The prevalence of chronic kidney disease in South Africa - limitations of studies comparing prevalence with sub-Saharan Africa, Africa, and globally |
title_full | The prevalence of chronic kidney disease in South Africa - limitations of studies comparing prevalence with sub-Saharan Africa, Africa, and globally |
title_fullStr | The prevalence of chronic kidney disease in South Africa - limitations of studies comparing prevalence with sub-Saharan Africa, Africa, and globally |
title_full_unstemmed | The prevalence of chronic kidney disease in South Africa - limitations of studies comparing prevalence with sub-Saharan Africa, Africa, and globally |
title_short | The prevalence of chronic kidney disease in South Africa - limitations of studies comparing prevalence with sub-Saharan Africa, Africa, and globally |
title_sort | prevalence of chronic kidney disease in south africa - limitations of studies comparing prevalence with sub-saharan africa, africa, and globally |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029276/ https://www.ncbi.nlm.nih.gov/pubmed/36944928 http://dx.doi.org/10.1186/s12882-023-03109-1 |
work_keys_str_mv | AT hariparshadsudesh theprevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally AT bhimmarajendra theprevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally AT nandlallouansha theprevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally AT jembereedgar theprevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally AT naickersaraladevi theprevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally AT assoungaalain theprevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally AT hariparshadsudesh prevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally AT bhimmarajendra prevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally AT nandlallouansha prevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally AT jembereedgar prevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally AT naickersaraladevi prevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally AT assoungaalain prevalenceofchronickidneydiseaseinsouthafricalimitationsofstudiescomparingprevalencewithsubsaharanafricaafricaandglobally |